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General Information
The Editors of The Journal of Thoracic and Cardiovascular Sur-
gery aim to promote excellence in the discipline and educate
those practicing and interested in our specialty. To this end, the
Journal accepts submissions in the form of original articles, brief
communications, editorials, and letters to the Editor on topics per-
taining to the most recent developments in cardiothoracic trans-
plantation, general thoracic surgery, surgery for acquired and
congenital cardiovascular disease, and technical and physiologic
issues as they relate to the specialty. The Journal commits to rig-
orous peer review, freedom from commercial influence, and
promotion of the highest ethical and scientific standards in our
specialty.
Editorial Policies
Review: Three or more referees are assigned to review each full
length original article. Acceptance is based on significance, original-
ity, and validity of the material presented. If the article is accepted
for publication, editorial revisions may be made to aid clarity and
understanding without altering the meaning. Authors are given the
opportunity to suggest one or more reviewers who they believe to
be expert and impartial in the field represented by the manuscript;
these reviewers may be selected at the Editor’s discretion.
Guidelines for Reviewers: Because more papers are submitted to
the Journal than can be published, only the very best papers should
be recommended for publication. Accordingly, a manuscript should
be evaluated not only with respect to its scientific competence and
accuracy, but also its relative importance in the field of thoracic
and cardiovascular surgery and for its probable interest to our read-
ership. Among the issues to consider are:
 What is the importance of the research question or subject field
study?
 Are the methods and experimental techniques adequate?
 Do the results seem to be reliable and presented clearly?
 Is the discussion relevant?
 Are the conclusions reasonable?
 Are the illustrations and references appropriate and necessary?
 Is the abstract informative and written in a style that will make
it intelligible to readers who do not work in the specific area ad-
dressed by the abstract?
 Is the writing clear and the organization of the paper sound?
 What is the originality of the work?
 Is the work too long?
If you recommend that a paper be shortened, you should indi-
cate on the form ‘‘Comments to Authors’’ in which places it could
specifically be abbreviated and which figures or tables could be
omitted, or placed for online viewing only with a reference in
the text. Please remember that it is the job of the copy editor to
identify typographical and syntactic errors. Please focus your
‘‘Comments to Authors’’ on queries and constructive criticism.
Do not put statements in the ‘‘Comments to Authors’’ form re-
garding the acceptability of the paper. If the editorial office or
the other reviewers decide to reject the paper, such statements
could be problematic. Reviewers should remember that manu-
scripts sent for review are confidential material and should only
be shared with others after explicit permission from the assigning
editor. Furthermore, reviewers should promptly report any conflict
of interest with the manuscript and/or authors to the assigning
editor.
Authorship and Scientific Responsibility: Only those individuals
whomade direct contributions to the intellectual content of the paper
may be listed as authors. Persons designated as authors should meet
all of the following criteria (see Consensus statement on surgery
journal authorship—2006. J Thorac Cardiovasc Surg 2006;131:
1221-2).
1. Made substantial contributions to conception and design,
and/or acquisition of data, and/or analysis and interpretation
of data
2. Participated in drafting the article or revising it critically for
important intellectual content
3. Gave final approval of the version to be submitted and any
revised version to be published
The authors should describe the role of the study’s sponsors in
the following areas:
1. Designing the study
2. Collecting, analyzing, and interpreting the data
3. Writing the report
4. Making the decision to submit for publication34A The Journal of Thoracic and Cardiovascular Surgery c February 2009
The JTCVS editorial staff will not consider for publication a re-
port in which the researcher did not have full access to the data, the
ability to analyze them independently from the sponsor, and sole
authority to make the final decision regarding publication. The ed-
itor may, if he deems it necessary, require a copy of the agreement
for verification of its content.
After a manuscript is accepted for publication, no author can be
removed from or added to the author list nor can the order of the
authors be changed without the written permission of all of the
manuscript authors.
Conflict of Interest: Each author of an original manuscript or brief
communication must submit a signed ‘‘JTCVS Disclosure State-
ment.’’ All positive disclosures related to an article accepted for pub-
lication will be reviewed by our Ethics Editor. When the Editor
believes a conflict exists, the journal will publish the disclosures
of the authors.
Authors who violate our disclosure policy will be denied the
privilege of publishing their work in our Journal for one to two
years, depending upon the severity of the offense.
Informed Consent: The Journal adheres to the principles set forth
in the Helsinki Declaration (http://www.wma.net/e/policy/b3.htm)
and holds that all reported research conducted with human partici-
pants should be conducted in accordance with such principles. Re-
ports describing data obtained from research conducted in human
participants must contain a statement in theMethods section indicat-
ing approval by the institutional review board and affirmation that
informed consent was obtained from each participant. If patients
are identifiable from illustrations, photographs, case reports, or other
study data, release forms (or copies of the figures with the appropri-
ate release statement) giving permission for publication must be sub-
mitted with the manuscript.
Humane Animal Care: All papers reporting experiments using an-
imals must include a statement in the Methods section giving assur-
ance that all animals have received humane care in compliance with
the Guide for the Care and Use of Laboratory Animals (www.nap.
edu/catalog/5140.html). Papers submitted from outside the United
States must be in compliance with the guidelines established by
their country’s government or those of the National Institutes of
Health and must include a statement to that effect in the Methods
section.
CONSORT Statement: All authors engaged in studies based on
randomized trials are asked to adhere to the principles outlined in
the CONSORT statement (http://www.consort-statement.org/), an
important research tool that takes an evidence-based approach to
improve the quality of reports of randomized trials. Manuscripts
reporting results of randomized controlled trials (RCTs) should
include the CONSORT flow diagram showing the progress of
patients through the trial (http://www.consort-statement.org). The
CONSORT checklist should also be completed and submitted
with the manuscript.
Consultant Statistician and Statistical Methods: All manuscripts
with statistical analysis are required to undergo biostatistical review
to ensure adequate and appropriate study design, analysis, interpreta-
tion, and reporting. The Journal requires that a biostatistician review
these manuscripts prior to submission. The most appropriate way to
involve a biostatistician is as a consultant or coauthor from the inves-
tigators’ home institution or collaborative group. The individualmust
review the Statistical Methods statement and complete and sign the
Statistical Collaboration/ReviewRelease Statement, available online
at ourmanuscript submission site http://www.editorialmanager.com/
jtcvs. Manuscripts may undergo further biostatistical review by the
Journal after submission. Additional information on statistical
methods can be found in ‘‘Uniform Requirements for Manuscripts
Submitted to Biomedical Journals’’ (www.icmje.org/index.html).
Copyright Statement: Copyright is obtained electronically via our
publisher, Elsevier Science, after manuscript acceptance. Please re-
spond promptly to their electronic communication in this regard.
Upon acceptance, authors must transfer all copyright ownership
of the manuscript to The American Association for Thoracic Sur-
gery. By completing the copyright, authors warrant that the article
is an original work without fabrication, fraud, or plagiarism; does
not infringe on any copyright or other proprietary right of any third
party; is not under consideration by another publication; and has not
been previously published. Authors also warrant that they each
meet the requirements for authorship enumerated in the Journal’s
Information for Authors and understand that if the paper or part
of the paper is found to be faulty or fraudulent, each shares the re-
sponsibility.
Dates of Receipt and Acceptance: The ‘‘received for publication’’
date is the date when the editorial office receives the complete man-
uscript via Editorial Manager. The ‘‘accepted for publication’’ date
is the date when the manuscript has met all of the requirements of the
editorial office regarding provision of the final revised manuscript,
illustrations meeting requirements for print reproduction, and signed
disclosure forms from all authors.
Registration of Clinical Trials: In 2004 the International Commit-
tee Of Medical Journal Editors (ICMJE) recommended that clinical
trials be registered in a public database as a prerequisite for subse-
quent publication (see De Angelis C, Drazen JM, Frizelle FA,
et al. Clinical trial registration: a statement from the International
Committee of Medical Journal Editors. N Engl J Med 2004;
351:1250-1). The Journal of Thoracic and Cardiovascular Surgery,
joining with the Surgical Journal Editors Group (SJEG), has agreed
to adopt this registration standard. The Editor now requires the pre-
registration of all prospective clinical trials that have a control
group, as well as any commercially-sponsored clinical trial, includ-
ing Phase I and II trials. Registration for retrospective reviews or
summaries of standard clinical treatment is not required. Clinical tri-
als that meet the above requirement and commenced after April 1,
2007 must be registered prior to enrollment of the first patient. Rel-
evant trials that began before this date must be registered prior to
editorial review. Registration must be indicated by providing the
unique study number assigned at www.clinicaltrials.gov, the princi-
ple site of registration sponsored by the National Library of Medi-
cine (NLM). Detailed directions and a tutorial for registering
a trial are available at http://prsinfo.clinicaltrials.gov (see Consensus
statement on mandatory registration of clinical trials. J Thorac Car-
diovasc Surg 2007;133:859-60).The Journal of Thoracic and Cardiovascular Surgery c Volume 137, Number 2 35A
Article Preparation
Manuscripts must be written so that a reasonably well-informed
member of the thoracic surgical community can understand
them. The primary goal of the Journal is the dissemination of infor-
mation and education. Arcane content must be explained and con-
sidered understandable by the editorial staff. Articles are chosen
based on their probability of achieving this goal. Authors are en-
couraged to follow the principles of clear scientific writing, such
as those described by Gopen and Swan,1 as well as Blackstone.2
All manuscripts must adhere to the length requirements
outlined below.
Note: To allow all manuscripts to be judged fairly, manu-
scripts exceeding length limitations are returned for short-
ening prior to review.
Original Research Article: The Journal publishes original research
in surgery and translational physiology as it relates to acquired and
congenital cardiovascular disease, cardiothoracic transplantation,
and general thoracic surgery. Meritorious work from closely related
specialties, such as anesthesiology, molecular biology, pathology,
pulmonary medicine, cardiology, and perfusion, is encouraged
and will receive appropriate consideration if the linkage to our spe-
cialty is clear.
Original research articles are grouped in the Journal according to
one of the following categories: Surgery for Acquired Cardiovascu-
lar Disease; Surgery for Congenital Heart Disease; General Thoracic
Surgery; Cardiopulmonary Support and Physiology; Evolving
Technology; Cardiothoracic Transplantation. Authors are asked to
self-categorize their articles during the submission process.
Note: Submission to the Journal constitutes an author decla-
ration that the manuscript is a single-journal submission and
has not been submitted to another journal simultaneously.
Length Requirements: Original research articles may not
exceed 7 printed pages, including title and abstract. The fol-
lowing guidelines offer the best approximation of appropriate
article length. Submitted articles that do not meet these guide-
lines will be returned to the corresponding author for appropri-
ate revision, prior to review.
 Title page, 250 word structured abstract, and a 50 word ul-
tramini-abstract
 A manuscript that contains no more than 3500 words in the
body of the text, excluding abstracts and references
 A maximum combination of 5 figures and/or tables. Addi-
tional figures or tables may be submitted for online only in-
clusion. A reference in the printed text will direct readers to
the additional online content.
 No more than 25 references
 A limit of 7 authors; exceptions are made for multi-center
trials and can be requested for other situations, provided
all authors meet the listed requirements
Please note that authors will be held to these limits at later re-
vision stages as well.
Brief Communication: The Editors are interested in brief clinical
contributions containing substantive information concerning clini-
cal studies or a pertinent observation. Accepted Brief Communica-
tions will be categorized by the editor into either clinical, technical,
or research subcategories. These submissions will be chosen on their
discussion and educational value and on their scholarly use of the
literature. Authors may be given the choice of (1) rapid publication
via on-line-only publishing or (2) normal publication schedule via
print and online.
Length Requirements: Brief communications should contain
no more than 750 words and 2 tables or figures, a limit of 4 au-
thors, and no more than 5 references. They do not need
a structured abstract or an ultramini-abstract.
Letters to the Editor: Readers are encouraged to submit commen-
tary on articles published in the Journal. Letters should be of broad
interest to readers and not designed to ‘‘split hairs.’’ Conflicting
opinions on broad issues are particularly welcome when documen-
tation is possible. Letters may be published together with a reply
from the original author. If the original author does not respond, a no-
tation indicating ‘‘Response declined’’ will be published. Substan-
tive Letters to the Editor are indexed in Index Medicus.
Length Requirements: Letters to the Editor should not exceed
500 words, 1 figure or table, 3 authors, and 5 references.
Manuscript Preparation
Title Page: Provide a concise, informative title, with no unneces-
sary words (e.g., Studies in . . .). List all authors’ academic degrees
and affiliations. Include all sources of funding for the work, all pos-
sible conflicts of interest, and complete name, address, telephone
and fax numbers, and e-mail address of the corresponding author.
Article word count on title page is required.
Abstract: The structured abstract (required for original manu-
scripts only) should be limited to 250 words, should not include ac-
ronyms or abbreviations, and should contain the following sections:
1. Objective(s): describe the hypothesis or the purpose of the
study
2. Methods: identify the study design and statistical methods
used
3. Results: describe the outcome of the study and the statistical
significance, if appropriate
4. Conclusions: state the significance of the results
Please provide a word count.
Ultramini-Abstract (required for original manuscripts only):
Provide 1 to 3 sentences of no more than 50 words total, containing
the essence of the manuscript, to include immediately beneath the
title of the paper in the table of contents.
Units of Measurement: Report measurements of length, height,
weight, and volume in metric units (meter, kilogram, or liter) or their
decimal multiples. Give temperatures in degrees Celsius and blood
pressures in millimeters of mercury. All hematologic and clinical
chemistry measurements should be reported in the metric system
in terms of the International System ofUnits (SI). The authors should
also add alternate or non-SI units before publication. See www.
acponline.org/journals/resource/unifreqr.htm for more details.
Abbreviations: Except for units of measurements, abbreviations
are discouraged. Abbreviations that are used should be defined at36A The Journal of Thoracic and Cardiovascular Surgery c February 2009
first mention. Internationally accepted abbreviations such as AIDS,
DNA, SD, TLC need not be defined. For commonly accepted abbre-
viations, word usage, symbols, and so forth, please consult Scien-
tific Style and Format3 and the American Medical Association
Manual of Style.4
References: Limit references to directly pertinent published works
or papers that have been accepted for publication. Original manu-
scripts are limited to 25 references, while brief communications
and letters to the editor are limited to 5 references. Unpublished
data and personal communications should be cited only in the
text, not as a numbered reference. Authors wishing to cite unpub-
lished material must have a letter of permission from the originator
of the communication to do so. This letter should be submitted with
the manuscript. Number references serially in the text and list them,
on a separate page, double-spaced, at the end of the paper in numer-
ical order.
Reference format should conform to that set forth in ‘‘Uniform
Requirements for Manuscripts Submitted to Biomedical Journals’’
(www.icmje.org/index.html) and journal abbreviations should con-
form to the style used in the Cumulated Index Medicus. The style
of citation should be as follows:
Journals: authors’ last names and initials; title of article; journal
name; date; volume number, and inclusive pages (list all authors
when six or fewer; when seven or more, list six and add et al):
Graeber GM, Gupta NC, Murray GF. Positron emission to-
mographic imaging with fluorodeoxyglucose is efficacious
in evaluating malignant pulmonary disease. J Thorac Cardi-
ovasc Surg 1999;117:719-27.
Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Ar-
nold JH, Akhrass R, et al. Two internal thoracic artery grafts
are better than one. J Thorac Cardiovasc Surg 1999;
117:855-72.
Books: authors’ last names and initials; chapter title, editor’s
name, book title, edition, city, publisher, date, and pages:
Mollnes TE. Analysis of in vivo complement activation: In:
Herzenberg LA, Weir DM, Herzenberg LA, Blackwell C,
editors. Weir’s Handbook of Experimental Immunology.
Volume 78, 5th ed. Boston: Blackwell Science; 1997, p.
78.1-78.8.
Figures: For help with preparing electronic artwork for both on-
screen review and eventual publication, see the information page
created by Elsevier Science (http://www.elsevier.com/wps/find/
authors.authors/authorartworkinstructions).
Figures must be of professional quality. When possible, please
use first-generation artwork. Number figures in the order of their
appearance in the text.
The Journal will reproduce free of cost to the author a reason-
able number of black and white illustrations and a limited number
of color illustrations. As we have a limited free color page budget,
please be sure that all figures that can be rendered in BW are done
so, and reserve color for images that will truly benefit the reader in
terms of comprehension. For instance, there should be no color in
graphs or tables. There is always the option to post additional fig-
ures online, or to have them appear in color online but BW in print.
We reserve editorial judgment as to which figures should be
printed in color.
Graph Creation: See http://www.editorialmanager.com/jtcvs for
more details.
Efficient Use of Space:
 Eliminate blank spaces that contain no information (e.g., delete
points on the x and y axes that do not contain data)
 Do not border a figure or a key with a box
 If they fit, place keys that apply to the figure within the figure
itself (without a box); if the key does not fit in the figure, place
it at the end of the legend (see Sample 2)
 Create figures in scale with each other to the extent possible
Effective Formatting:
 Do not use background horizontal lines
 Avoid 3-dimensional art
 Make sure both axes are labeled
 Most figures will be one column wide. Ensure that all data and
type within a figure are sized according to these guidelines to
the extent possible
 Use upper- and lowercase type: It is much easier to read than all
capital letters
 Use a consistent typeface and size (Helvetica or Universe, 11 or
12 points) throughout (avoid sans serif types, such as Courier)
 Use a bold typeface for emphasis; it is much more readable that
italics or underlining
 Avoid gray shading; it does not reproduce well
 Make lines thick enough to ensure adequate reproduction
(extremely thin lines do not reproduce well)
General Instructions:
 For figures submitted in electronic format, all images should be
at least 5 inches wide. Images should be provided in EPS or TIF
format
 Graphics software such as Photoshop and Illustrator, not pre-
sentation software such as PowerPoint, CorelDraw, or Harvard
Graphics, should be used to create art
 Color images need to be CMYK, at least 300 dpi, accompanied
by a digital proof
 Gray scale images should be at least 300 dpi accompanied by
a proof
 Line art (black and white or color) and combinations of gray
scale and line art should be at least 1200 dpi and accompanied
by a proof
 For best reproduction, avoid screening, shading, and lettering
on a dark background
Tables: Tables should be self-explanatory and should supplement,
not duplicate, the text. Each table should be on a separate page. Pro-
vide a brief title for each. Abbreviations used in table should be de-
fined at the bottom of the table.
Manuscript Submission
Electronic Submission: All manuscripts must be submitted via
Editorial Manager (http://jtcvs.editorialmanager.com) and should
include the following items:
 Abstract and mini-abstract (original manuscripts only)
 Title page with word count
 Manuscript (using word processor file)
 TablesThe Journal of Thoracic and Cardiovascular Surgery c Volume 137, Number 2 37A
Note: Please include abstract, mini-abstract, title page,
manuscript, tables, and figure legends in one file
 Figures (attach as separate files)
You may also submit the name of one reviewer of your choice.
You should include that individual’s e-mail address. Assigning
suggested reviewers is done at the discretion of the editor handling
your manuscript. If the reviewer you suggest is asked to review the
manuscript, his or her identity will be kept confidential.
The following items that accompany the manuscript must be
scanned and submitted electronically or submitted by mail if scan-
ning is not an option:
 JTCVS Disclosure Statement
 Permission to reproduce published material (if applicable)
 Statistical Collaboration/Review Statement (if applicable)
General Guidelines:
 Note: It is the corresponding author’s responsibility to en-
sure that each submitted version of the manuscript is the
correct version.
 Format all text elements as double spaced for easier reading
 Insert page breaks between the title page, abstract, ultramini-ab-
stract, and first page of text.
 Begin text, acknowledgements, references, and figure legends,
respectively, on separate pages.
 Begin each table on a separate page.
 Write text in clear and concise language, using accepted standards
of English style and usage. Define unfamiliar or new terms when
first used and avoid use of jargon, cliche´s, and laboratory slang.
 On the title page, include the title of the article and the author(s)
name(s), degree(s), and institutional affiliation(s) as well as the
name, telephone number, fax number, and e-mail address of the
corresponding author. Where necessary, identify each author’s
affiliation by superscript numbers matched to the appropriate in-
stitutions. Also include word count of manuscript (required).
Note: To view your manuscript in PDF format on Editorial
Manager, you must have Adobe Acrobat Reader 8.0 in-
stalled on your computer.
Manuscript Revision: Revised manuscripts must be submitted in
two parts as word-processing files (pdf files are not acceptable):
(1) revised, marked manuscript showing additions and deletions,
preferably using strike through format for deletions; (2) revised, un-
marked manuscript.
Manuscript Processing
Acknowledgment of Receipt: Each submission is assigned a unique
number and acknowledged by e-mail. The editorial office considers
the manuscript number a confidential communication, which should
be given only to other authors of the paper. The editorial office staff
releases information about manuscripts only to authors who provide
the manuscript number. Information about a specific manuscript can
be obtained via Editorial Manager only by the corresponding author
or his designated representative who has access to his personal user-
name and password.
NIH Initiative: The National Institutes of Health ‘‘requests and
strongly encourages’’ NIH-funded investigators to submit an elec-
tronic version of their final manuscript resulting from research sup-
ported in whole or in part with direct costs from NIH, on acceptance
for publication, to PubMed Central (PMC) (http://www.
pubmedcentral.nih.gov). The final manuscript is the version con-
taining all modifications from the publishing peer review process.
Our Journal supports those authors who wish to participate in this
initiative but does not participate in the submission process. Our
publisher does participate in the submission process and you can
work with them to ensure deposit of your manuscript.
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Checklist
— JTCVS Disclosure Statement signed, one from each author
— Permission to reproduce published material or to cite unpub-
lished data
— Informed consent statement (in Methods)
— Humane animal care statement (in Methods)
— Funding agency’s role in data interpretation (in Methods)
— Signed Statistical Collaboration/Review Release Statement
— Clinical Trial Registry Number (if applicable)
— Original manuscript submitted viajtcvs.editorialmanager.com
(abstract, mini-abstract, title page, manuscript, references,
tables, and figure legends in one file)
— Title page
— Title of article
— Full name(s), academic degrees, and affiliation(s) of authors
— Corresponding author
— Telephone (business and home), fax, and e-mail address
for corresponding author
— Word count (required)
— Abstract (250 words; double-spaced; for original manuscripts
only)
— Ultramini-abstract (50 words; double-spaced; for original
manuscripts only)
— Text (double-spaced)
— References (double-spaced; separate pages)
— Tables (double-spaced; separate pages)
— Figure legends (double-spaced; separate pages)
— Figures (separate files; no paperclips on hardcopy; properly
identified)38A The Journal of Thoracic and Cardiovascular Surgery c February 2009
